Topic Listing for Intec Pharma Ltd.

Ability Obtain Funds Necessary Operations Access Information
Accounting Restructuring Costs Accounts Receivable
Accounts Receivable Other Current Assets Accrued Expenses
Acquired Intellectual Property Acquired Intellectual Property Net
Acquisition Proposals Action Steering Committee Dispute Resolution
Activity Actual Results Differ Materially Expressed Implied Forward-looking Statements
Additional Agreements Additional Information Asset Sales Plan Liquidation
Additional Information Find Adjustment Officer Base Salaries
Advance Notice Requirements Next Annual Meeting Adverse Change Employees Title
Affiliate Agree Resolve Commit Foregoing
Agreements Employees Allocation Between Different Compensation Elements
Amended Amended Restated Employment Agreement
Amendment Novo Nordisk Agreement Amendment Termination Plan
Amendments Annex
Annual Bonuses Arrange Provision Employee Reasonable Executive Outplacement Services Provider
Asset Purchase Agreement Assignment
Assignment Neose 641 Assignment Non-compete
Assumed Liabilities Excluded Audit Committee
Authority Binding Agreements Automatic Non-employee Director Option Grants
Background Base Salaries
Beneficial Ownership Reporting Compliance Binding Effect
Biogenerix Biogenerix Agreements
Blocking Patent Board Committee Meetings Held 2004
Board Directors Board Directors Recommends Vote Each Nominees
Board Means Directors Brian Davis Appointed Neose Cfo
Broker-dealer Status Business Strategy
Calendar Cannot Sure Asset Sales Completed
Capital Lease Obligations Case Above Reasonably Expected Materially Delay Prevent Consummation
Cash Equivalents Cautionary Statement Pursuant Safe Harbor Provisions Private Securities
Certain Assignments Neose Certain Closing Deliveries Buyer Shall Delivered Caused Seller
Certain Closing Deliveries Seller Shall Delivered Caused Buyer Certain Effects Termination
Certain Relationships Related Transactions Certain Tax Matters
Certificate Dissolution Closing Stock Transfer Books Certification Chief Executive Officer
Certification Chief Financial Officer Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Change Control Agreement Change Control Means Ownership Effected Through
Change Vote Changes Internal Control Over Financial Reporting
Changes Steering Committee Classification Measurement Statement
Code Conduct Code Means Internal Revenue 1986 Amended
Collaboration Supply Agreements Collaborative Agreements Significant Customer Concentration
Commercial Sale Commercially Reasonable Efforts
Committees Board Committees Board Directors
Common Stock Common Stock Performance Graph
Compensation Actions Compensation Benefits Expense Reimbursements
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Philosophy Competition
Completion Acquisition Disposition Assets Comply Applicable Rules Regulations
Comprehensive Loss Conditions Precedent
Conduct Conference Call
Confidential Information Conflict Result Breach Certificate Incorporation Bylaws Other Constitutive
Connection Policies Scheduled Page Agent Represents Warrants Cananwill Consent Other Party
Construed Efforts Prudent Person Such Partys Industry Desirous Contacts
Contents Continuing Education Directors
Contracts Control Controlled
Controls Procedures Cooperation
Copies Referenced Documents Corporate Governance Committee
Corporate Transactions Costs Associated Exit Disposal Activities
Count Votes Counterparts
Counterparts Agreement Executed Multiple Each Deemed Original Together Create Incur Assume Suffer Exist Otherwise Liable Respect
Creation Direct Financial Obligation Creation Direct Financial Obligation Off-balance Sheet Arrangement
Creation Modification Work Plan Critical Accounting Policies Estimates
Cumulative Remedies Provided Herein Not Exclusive Other Law Current Director Not Standing Re-election Board
Current Report Pursuant Securities Exchange Act 1934 Date
Date Report Earliest Event Reported 2005 Dated 2007
Debt Financing Activities Deferred Financing Costs
Deferred Rent Landlord Incentive Deferred Revenue
Definitions Definitions Used Herein
Delivery Notice Pursuant 513 Shall Not Limit Otherwise Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Deposits
Description 2004 Equity Incentive Plan Descriptive Headings Convenience Only Shall Not Control Affect
Descriptive Headings References Designated Representative
Determining Compensation Chief Executive Officer Directors Attendance Meeting
Directors Executive Officers Registrant Directors Seller Determines Good Faith Failure Take Such
Disclosure Controls Procedures Documents Incorporated Reference
Elements Compensation Eligibility
Employee Benefit Plan Policy Arrangement Accordance Terms Such Employee Matters
Employees Employees Located United States
Employment Engage Participate Business Competitive
Engage Participate Business Competitive Defined Below Entire Agreement
Entitled Vote Annual Meeting Votes They Entry Material Definitive Agreement
Environmental Matters Epresentations Warranties Buyer
Equipment Loans Equity Compensation Plan Information
Equity Financing Activities Equity Incentive Plans
Equity Price Risk Establishment Responsibilities Steering Committee
Estimates Examiner Uspto Proposes Base Such Interference
Except Set Forth Below Undersigned Not Beneficial Registered Execution Version
Executive Compensation Executive Officers
Exhibits Exhibits Index
Expectations Regarding Timing Character New Expanded Collaborations Performance Expenses Contract Research Development Service Providers
Explanatory Exploratory Research Program
Export Laws Regulations Fair Value Disclosures
Fair Value Financial Instruments Federal Income Tax Consequences Plan
Financial Statements Exhibits Financial Statements Pro Forma Information Exhibits
Financial Statements Supplementary Data Financing Costs Related Long-term Debt
Foreign Exchange Risk Form 10-k
Form 10-k Amendment Form 10-q
Form Required Agreement Proposed Sublicensees Forward-looking Information Subject Risk Uncertainty
Forward-looking Statement General
General Administrative Expense George Vergis Phd
Glycoadvance Glycopegylation Glycopegylated Products Development
Glycopegylation Gmps
Governing Law Governing Law Agreement Shall Governed Construed Accordance Laws
Governing Law Jurisdiction Venue Service Process Government Regulation
Impairment Long-lived Assets Improvements
Incentive Stock Options Income Tax Benefit
Income Taxes Incur Significant Costs Connection Asset Sales Whether Not
Ind Independence Directors
Independent Contractors Independent Registered Public Accounting Firm They Represented Annual
Index Index Exhibits
Indirect Expenses Information Contact Department Financial Institutions State California
Information Please Visit Wwwneosecom Insured Jointly Severally Agrees Follows
Intangible Other Assets Intellectual Property
Interest Expense Interest Expense Each 2006 2005 Was Recent Accounting
Interest Rate Risk Interim Financial Information
Internal Revenue Code 162 Internet Address Securities Exchange Act Filings
Investing Activities Joint Improvements
Know-how Lease Termination Costs
Leases License Fees Multiple Element Arrangements
Licenses Neose Liquidating Distributions
Liquidity Capital Resources Long-lived Tangible Assets
Long-term Debt Capital Lease Obligations Managements Discussion Analysis Financial Condition Results Operations
Managements Report Internal Control Over Financial Reporting Manufacturing
Market Registrants Common Equity Related Stockholder Matters Marketable Securities
Marketing Distribution Sales Marketing Distribution Sales Proprietary Protein Products
Material Impairments Meetings
Merge Consolidate Other Person Restructure Reorganize Completely Partially Milwaukee Avenue Glenview 60025 800 544-0666
Miscellaneous Modification 2004 Bonus Awards Officers
Modification 2005 Bonus Awards Officers Mutual Nondisclosure Agreement
Mutual Written Agreement Buyer Seller Name
Nasdaq Global Market Neose
Neose Biogenerix Announce Agreement Glycopegylated Next Generation Protein Neose Biogenerix Enter Commercial Agreement Glycopegylated Next Generation
Neose Improvements Neose Know-how
Neose Patents Neose Project-related Costs
Neose Technologies Announces Closing Asset Sales Novo Nordisk Neose Technologies Announces Voluntary Delisting Nasdaq Closing Stock
Neose Technologies Appeal Nasdaq Global Market Delisting Notification Neose Technologies Common Stock Continues Listing Nasdaq Global
Neose Technologies Common Stock Delisted Nasdaq Global Market Neose Technologies Inc
Neose Technologies Inc 2004 Equity Plan Neose Technologies Receives Additional Staff Determination Nasdaq Global
Neose Technologies Reports Financial Results Neose Technologies Sell Assets Novo Nordisk Biogenerix
Neose Technology Net Loss Per Share
Net Sales New Product
Nomination Directors Nominees Election
Non-competition Agreement Non-disclosure
Non-employee Stock Options Non-qualified Stock Option Award Agreement
Non-qualified Stock Options Non-use
Nonqualified Deferred Compensation 2007 Not Undertake Duty Update After Date Report Forward-looking
Notes Financial Statements Except Per Share Amounts Accounts Notes Financial Statements Except Per Share Amounts Accrued
Notes Financial Statements Except Per Share Amounts Collaborative Notes Financial Statements Except Per Share Amounts Debt
Notes Financial Statements Except Per Share Amounts Impairment Notes Financial Statements Except Per Share Amounts Intangible
Notes Financial Statements Except Per Share Amounts Organization Notes Financial Statements Except Per Share Amounts Property
Notes Financial Statements Except Per Share Amounts Related-party Notes Financial Statements Except Per Share Amounts Supplemental
Notes Payable Equipment Lender Notice
Notice Annual Meeting Stockholders Held 2005 Notice Certain Events Each Party Shall Promptly
Novo Improvements Novo Materials
Novo Nordisk Novo Nordisk Agreements
Novo Technology Now Therefore
Number 0-27718 Obtain Copy Neoses Form 10-k Additional Copies Proxy
Off-balance Sheet Arrangements Operating Activities
Operating Leases Opportunities Protein Market
Opportunities Therapeutic Protein Market Option Grant
Option Grants Plans Not Approved Stockholders Organization Business Activities
Original Work Plan Other Events
Other Glycotechnology Programs Other Income
Other Income Expense Other Requirements
Overview Overview Transaction Biogenerix
Overview Transaction Novo Nordisk Ownership Rights
Paid Parachute Payments
Part Other Information Partnering Licensing Program
Party Party Beneficiaries
Patent Rights Pay Employee Date Termination Lump Sum Cash Payment
Payable Secured Insurance Policies Payment
Payment Withholding Taxes Payments
Payments Benefits Described Sections Lieu Not Addition Other Permit
Person Personally Mailing Registered Certified Mail Postage Prepaid Return
Plan Benefits Portions Omitted Filed Separately Secretary Pursuant Application Confidential
Potential Nasdaq Delisting Common Stock Potential Payments Termination Change Control
Pre-approval Policies Procedures Prepaid Expenses Other Current Assets
Preparation Proxy Statement Stockholders Meeting Principal Accountant Fees Services
Prior Art Relevant Thereto Other Impediment Render Claims Procedure Effect Termination
Process Product
Profile New Factor Product Project
Project Manager Project Managers
Properties Property
Property Equipment Proposed Amendment
Proposed Asset Sales Plan Liquidation Proprietary Drug Development Portfolio
Provides Update Corporate Objectives Proxy Statement
Proxy Vote Shares Purchase Obligations
Purchase Obligations Employment Agreements Purchase Price Allocation
Purchase Sale Assets Price Purchased Assets Excluded
Quantitative Qualitative Disclosure Market Risk Quantitative Qualitative Disclosures Market Risk
Read Combination Entitled Managements Discussion Analysis Financial Condition Reagents
Reasonable Care Receivable Related Party
Recent Accounting Pronouncements Recent Changes
Recitals Reclassification
Registration Payment Arrangements Outstanding Shares Warrant Regulated Market
Regulation Disclosure Regulatory Approval
Regulatory Matters Reimbursement Research Development Costs
Related-party Transactions Relationships
Release Means Substantially Identical Attached Hereto Remedies Enforcement Breach
Report Independent Registered Public Accounting Firm Representations Warranties Seller
Require Additional Capital Fund Operations Event Determine Unable Required Stockholder Vote Shall Been Obtained
Requirements Written Notice Intent Research Deliverables
Research Development Research Development License Agreement
Responsibility Liabilities Obligations Seller Other Assumed Specifically Identified Restricted Period Extended Eighteen
Restricted Share Units Restricted Shares
Restricted Shares Share Units Restricted Stock Units
Restrictive Covenants Means Set Forth Sections Agreement Restructuring
Restructurings Employee Severance Costs Result Creation Imposition Lien Other Permitted Liens Purchased
Results Operations Financial Condition Revenue Recognition
Risk Factors Risks Related Competition
Risks Related Development Products Technologies Risks Related Facilities Business Interruption Environment
Risks Related Government Regulation Risks Related Intellectual Property
Risks Related Stock Market Safe Harbor Statement Private Securities Litigation Reform Act
Savings Plan Scientific Review Committee
Securities Registered Pursuant Act Security Ownership Certain Beneficial Owners Management
Sell Lease Otherwise Transfer Create Incur Lien Within Seller Timely Filed Income Tax Returns Required Federal
Selling Securityholder Notice Questionnaire Separation Retirement Agreements
Severability Severance Change Control Arrangements
Severance Payments Signature Page Follows
Signatures Significant Customer Concentration
Similar Fee Directly Indirectly Connection Transactions Contemplated Hereby Soliciting Proxies They Being Solicited Pays Cost
Special Regarding Forward-looking Statements Steering Committee
Stock Appreciation Rights Stock Options
Stock Options Appreciation Rights Stock Options Long-term Incentives
Stock Transfer Books Close Date Certificate Dissolution Secretary Stock-based Compensation
Stock-based Employee Compensation Stockholder Proposals Next Annual Meeting Due
Stockholders Approve Asset Sales Vote Against Other Sale Stockholders Approve Asset Sales Vote Against Plan Liquidation
Stockholders Equity Subject Customary Closing Conditions Including Stockholder Approval Asset
Subject Lieu Payments Benefits Provided Pay Executive Cash Sublicense Agreement
Submission Matters Vote Security Holders Subsequent Event
Substantive Milestone Payments Summary Compensation Table
Summary Contractual Obligations Supplemental Disclosure Cash Flow Information
Supply Agreement Supply Option Agreement
Supply Period Supply Protein
Survival Table Contents
Tax Accounting Considerations Affecting Executive Compensation Taxes
Technology Term
Term Loan Bank Industrial Development Authority Bonds Term Loan Landlord
Termination Termination Material Definitive Agreement
Termination Without Cause Good Reason Terms
Timing Payments Following Termination Top Form
Trademark Transactions Contemplated Hereby Thereby Compliance Buyer Provisions Hereof
Transferred Know-how Transition Period
Unanimously Unregistered Sales Equity Securities
Valid Patent Claim Voluntary Delisting Nasdaq
Vote Vote Required Recommendation
Waiver Warrant Liability
Warrant Value What Constitutes Quorum
What Percentage Common Shares Directors Officers Own What Proxy
What Vote Required Approve Each Proposal What Voting
Whereas Witmer Road Horsham Pennsylvania 19044
Witness Whereof Work Plan
Work Plan Costs 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki